UNSPSC 85534008: Bypass inferior mesenteric vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass inferior mesenteric vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06164KY

UNSPSC 85534008 Bypass inferior mesenteric vein to lower vein with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity for state and local procurement. The code describes a specific surgical procedure—vascular bypass using synthetic material via endoscopic technique—yet the recent state and local opportunities posted under this code involve occupational medical surveillance, independent medical evaluations for disability determinations, pharmacy benefit management, temporary health professional staffing, and surgical benefit carve-outs. None of these solicitations align with the procurement, delivery, or supply of the bypass procedure itself. The mismatch between the code's nominal scope and the actual work being solicited suggests either miscoding on the part of issuing bodies or that this Commodity code does not capture genuine state and local contracting activity for vascular bypass services.

State and local procurement offices in Arizona, California, Florida, and Washington have posted opportunities under this code in recent weeks, but they reflect administrative health services, benefits management, and staffing procurement rather than surgical procedures or medical devices. Without evidence of actual bypass-procedure-related solicitations—such as physician networks contracting to perform the procedure, surgical supply agreements, or facility-based surgical service contracts—this code does not present a viable market signal for vendors supplying vascular bypass services or related inputs to state and local health systems.